Several typographical errors occurred on page 125 in Table 2 of an article in the Mar/Apr 2005 issue of JAMIA (Rubin DL, Thorn CF, Klein TE, Altman RB. A statistical approach to scanning the biomedical literature for pharmacogenetics knowledge. J Am Med Inform Assoc. 2005; 12, 121–9.) The corrected table follows.
Table 2.
Highest-Ranking MeSH Terms and Words for Identifying Pharmacogenetics Articles
| Words/MeSH Terms Ranked by χ2 | MeSH Terms Ranked by Log-Likelihood Score |
|---|---|
| 2b6 | Histamine N-Methyltransferase |
| 2c19 | Sulfaphenazole |
| 2c9 | Purine-pyrimidine metabolism, inborn errors |
| 2d6 | Proto-oncogene proteins c-rel |
| 20 | Glucuronic acids |
| 6-Mercaptopurine | p-Aminosalicylic acid |
| 6mp | Thioinosine |
| Administration, oral | Reovirus 3 |
| Area under curve | Protein subunits |
| Cytochrome P-450 CYP2D6 | Orphenadrine |
| Debrisoquin | Organic cation transport proteins |
| Double-blind Method | Organic anion transport polypeptide C |
| Hydroxylation | Histamine N-methyltransferase |
| Metabolic clearance rate | Sulfaphenazole |
| Omeprazole | Purine-pyrimidine metabolism, inborn errors |
| Pharmacogenetics | Pronto-oncogene proteins c-rel |
| Treatment Outcome | Nordazepam |
| a118g | Hexobarbital |
| acei | Hepatocytes |
| albuterol | Equilibrative nucleoside transporter 1 |
| alox5 | Histamine N-methyltransferase |
| alqt | Sulfaphenazole |
| amiodaron | Purine-pyrimidine metabolism, inborn errors |
| amitriptylin | Proto-oncogene proteins c-rel |